Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Weight Loss 2Stomach Neoplasms 2Malnutrition 2Esophageal Neoplasms 2Pituitary Neoplasms 1Periampullary Tumors 1Pancreatic Neuroendocrine Tumor G2 1Pancreatic Neoplasms 1Lymphocele 1Endocrine System Diseases 1Duodenal Neoplasms 1Breast Neoplasms 1Acromegaly 1

Interventions

Standard of Care 18Gemcitabine 18Radiosurgery 14Drug Therapy 13Blood Specimen Collection 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 11Exercise 10Pancreaticoduodenectomy 9Practice Guidelines as Topic 8Methods 8Magnetic Resonance Spectroscopy 8Biopsy, Fine-Needle 8Capecitabine 7Early Intervention, Educational 6Biopsy 6Surveys and Questionnaires 5Stents 5Specimen Handling 5Resistance Training 5Radiofrequency Ablation 5Psychiatric Rehabilitation 5Oxaliplatin 5Fluorouracil 5Cholangiopancreatography, Endoscopic Retrograde 5130-nm albumin-bound paclitaxel 5Secretin 4Radiotherapy 4Irinotecan 4Heavy Ion Radiotherapy 4Electroporation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Neoplasms × Octreotide × Clear all
NCT02381249 2023-11-27

The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery

St. James's Hospital, Ireland

Phase NA Completed
40 enrolled
Gastrointestinal

Duodenal Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Weight Loss, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡